Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor

PLoS One. 2017 Oct 17;12(10):e0186450. doi: 10.1371/journal.pone.0186450. eCollection 2017.

Abstract

It has been proposed that some non-retroviral RNA virus genes are integrated into vertebrate genomes. Endogenous filovirus-like elements (EFLs) have been discovered in some mammalian genomes. However, their potential roles in ebolavirus infection are unclear. A filovirus VP35-like element (mlEFL35) is found in the little brown bat (Myotis lucifugus) genome. Putative mlEFL35-derived protein (mlEFL35p) contains nearly full-length amino acid sequences corresponding to ebolavirus VP35. Ebola virus VP35 has been shown to bind double-stranded RNA, leading to inhibition of type I interferon (IFN) production, and is also known as a viral polymerase cofactor that is essential for viral RNA transcription/replication. In this study, we transiently expressed mlEFL35p in human kidney cells and investigated its biological functions. We first found that mlEFL35p was coimmunoprecipitated with itself and ebolavirus VP35s but not with the viral nucleoprotein. Then the biological functions of mlEFL35p were analyzed by comparing it to ebolavirus VP35s. We found that the expression of mlEFL35p significantly inhibited human IFN-β promoter activity as well as VP35s. By contrast, expression of mlEFL35p did not support viral RNA transcription/replication and indeed slightly decrease the reporter gene expression in a minigenome assay. These results suggest that mlEFL35p potentially acts as an IFN antagonist but not a polymerase cofactor.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Chiroptera / virology
  • Ebolavirus / genetics*
  • Ebolavirus / isolation & purification
  • Ebolavirus / metabolism
  • Gene Expression
  • Genes, Reporter
  • HEK293 Cells
  • Host-Pathogen Interactions*
  • Humans
  • Interferon-beta / antagonists & inhibitors*
  • Interferon-beta / genetics
  • Interferon-beta / immunology
  • Luciferases / genetics
  • Luciferases / metabolism
  • Nucleocapsid Proteins
  • Nucleoproteins / genetics*
  • Nucleoproteins / metabolism
  • Promoter Regions, Genetic
  • Protein Binding
  • RNA, Double-Stranded / genetics*
  • RNA, Double-Stranded / metabolism
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Sequence Alignment
  • Sequence Homology, Amino Acid
  • Viral Core Proteins / genetics*
  • Viral Core Proteins / metabolism
  • Virus Replication

Substances

  • Nucleocapsid Proteins
  • Nucleoproteins
  • RNA, Double-Stranded
  • Recombinant Proteins
  • Viral Core Proteins
  • nucleoprotein VP35, Ebola virus
  • Interferon-beta
  • Luciferases

Grants and funding

This work was supported by Japan Society for the Promotion of Science (JSPS), Grant number 16J04404, https://www.jsps.go.jp/english/index.html (T.K. received this funding); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Grant number 15FM0108008H0001, http://www.amed.go.jp/en/program/list/01/06/023.html (A.T. received this funding); Science and Technology Research Partnership for Sustainable Development (SATREPS), Grant number 15JM0110005H0004, http://www.jst.go.jp/global/english/index.html (A.T. received this funding); JSPS and the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant numbers 16H02627 and 15H01249, https://www.jsps.go.jp/english/index.html, http://www.mext.go.jp/en/ (A.T. received this funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.